Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA

The Journal of Clinical Investigation
O F WagnerH Pannekoek

Abstract

Plasminogen activation is catalyzed both by tissue-type-(t-PA) and by urokinase-type plasminogen activator (u-PA). This reaction is controlled by plasminogen activator inhibitor type 1 (PAI-1) that is either present in plasma or bound to fibrin, present in a thrombus. We studied the mechanism of in vitro inhibition of both t-PA and u-PA activity by PAI-1 bound to fibrin. It is shown that activation of latent PAI-1 unmasks a specific fibrin-binding site that is distinct from its reactive site. This reactive site of activated PAI-1 bound to fibrin is fully exposed to form complexes with t-PA and u-PA, that are unable to activate plasminogen. Upon complex formation with either one of the plasminogen activators, PAI-1 apparently undergoes a conformational change and loses its affinity for fibrin. Consequently, complexes of u-PA and PAI-1 dissociate from the fibrin matrix and are encountered in the fluid phase. In contrast, t-PA/PAI-1 complexes remain bound to fibrin. By employing recombinant t-PA deletion-mutant proteins, that precisely lack domains involved in fibrin binding, we demonstrate that binding of t-PA/PAI-1 complexes is mediated by both the "finger" (F) and the "kringle-2" (K2) domain of t-PA. A model is proposed that ex...Continue Reading

References

Jul 1, 1978·The Journal of Experimental Medicine·A Granelli-Piperno, E Reich
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·F Colbere-GarapinA C Garapin
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A J van ZonneveldH Pannekoek
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T NyD J Loskutoff
Jan 1, 1986·Journal of Cellular Biochemistry·A J van ZonneveldH Pannekoek
Dec 1, 1986·The Journal of Clinical Investigation·D GinsburgT D Gelehrter
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Dec 21, 1984·Nucleic Acids Research·W KramerH J Fritz
Jan 1, 1983·Annual Review of Biochemistry·J Travis, G S Salvesen
Jan 1, 1984·Seminars in Thrombosis and Hemostasis·N Aoki, P C Harpel
Jan 24, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·B WimanM Rånby
Jan 24, 1981·Nucleic Acids Research·J MessingP H Seeburg
Dec 7, 1984·Journal of Chromatography·B A BidlingmeyerT L Tarvin
Oct 1, 1984·The Journal of Clinical Investigation·L A EricksonD J Loskutoff
Feb 1, 1980·The Journal of Clinical Investigation·Y Sakata, N Aoki
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D J LoskutoffD Lawrence

❮ Previous
Next ❯

Citations

Oct 7, 1998·Protein Science : a Publication of the Protein Society·S S AnM Llinas
Jan 12, 2002·Biochemical and Biophysical Research Communications·Iris SchvartzShmuel Shaltiel
Jan 1, 1994·Journal of Neuro-oncology·J S RaoR Sawaya
Jan 1, 1993·International Journal of Clinical & Laboratory Research·D PriscoG F Gensini
Dec 9, 2000·European Journal of Drug Metabolism and Pharmacokinetics·E MuneerV M Doctor
Apr 28, 1994·Biochimica Et Biophysica Acta·F SamadD L Amrani
Dec 2, 1990·Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists·D SeiffertD J Loskutoff
May 1, 1998·Trends in Cardiovascular Medicine·S StefanssonD A Lawrence
Jun 15, 2000·The New England Journal of Medicine·H P Kohler, P J Grant
Oct 1, 1994·Journal of Internal Medicine·H R LijnenS Thorsen
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·N BrünnerR W Stephens
Feb 15, 2005·International Journal of Clinical Practice·M Agirbasli
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Martina L Sanderson-SmithJason D McArthur
Mar 3, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomohiro SakamotoHisao Ogawa
Feb 12, 2004·Insect Biochemistry and Molecular Biology·Weon-Kyoo YouKwang-Hoe Chung
Mar 16, 2004·British Journal of Haematology·Anton J G Horrevoets
May 4, 2001·The American Journal of Cardiology·D E Vaughan
Mar 15, 1994·Thrombosis Research·C KrishnamurtiB M Alving
Jun 1, 1995·Baillière's Clinical Haematology·H R Lijnen, D Collen
Oct 7, 2015·Frontiers in Cellular Neuroscience·Sophia BardehleKaterina Akassoglou
Jun 17, 2014·Journal of Vascular and Interventional Radiology : JVIR·Melanie B SchernthanerHeiko Uthoff
Jan 28, 2006·Biochemical and Biophysical Research Communications·Rita GalántaiRaymund Machovich
Oct 31, 2008·Trends in Neurosciences·Manuel YepesDenis Vivien
Nov 11, 1999·British Journal of Haematology·G J LockerO F Wagner
Sep 8, 2001·Critical Care Medicine·P D SchellingerW Hacke
Mar 3, 2009·Tissue Engineering. Part B, Reviews·Ailish BreenAbhay Pandit
Sep 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C F ReillyM E Siegfried
Oct 1, 1995·Circulation·D V Sakharov, D C Rijken
Oct 8, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Katarzyna SmolarczykCzeslaw S Cierniewski
Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·W P FayW G Owen
Dec 4, 1992·Annals of the New York Academy of Sciences·G D Lowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.